About Us

Nuvista Pharma PLC. (formerly Organon Bangladesh Limited) has a rich heritage rooted in its beginnings as a subsidiary of Organon International, the Netherlands-based pharmaceutical giant. Established in 1964, Nuvista Pharma has played a significant role in the pharmaceutical landscape of Bangladesh, operating a local manufacturing facility in Tongi, Gazipur, near the capital city, Dhaka. After Organon divested its ownership to local management in 2006, the Company was renamed Nuvista Pharma Limited, and in 2018, Beximco Pharma acquired a majority shareholding (85.22%), enhancing its capabilities and reach.

Building on Organon’s legacy of quality and manufacturing excellence, Nuvista Pharma specializes in a wide range of pharmaceutical products that include hormone therapies, steroids, and various general medicines. The Company’s offerings span multiple dosage forms, such as tablets, capsules, injectables, and ophthalmic solutions, each developed with strict quality standards to meet healthcare demands. In particular, Nuvista Pharma has a dominant presence in the oral contraceptives market and is highly regarded for its expertise in hormone and steroid products, underscoring its role as a pioneer in these areas.

Driven by a core purpose to “provide unconditional care to women and their families for a more empowered womanhood,” Nuvista Pharma aims to create a world where women’s health and family well-being are prioritized, leading to a healthier, safer, and more informed society. The Company is dedicated to making a tangible impact on women’s health today for a better tomorrow, all while advancing human life.

The Company employs over 1,000 full-time employees from a broad spectrum of backgrounds, including pharmacists, doctors, engineers, chemists, microbiologists, accountants, and graduates. Through its broad product portfolio and dedicated workforce, Nuvista Pharma remains committed to empowering women and enhancing family health across the nation.